Ng IO - Search Results

1

Novel pre-mRNA splicing of intronically integrated HBV generates oncogenic chimera in hepatocellular carcinoma.

Chiu YT, Wong JK, Choi SW, Sze KM, Ho DW, Chan LK, Lee JM, Man K, Cherny S, Yang WL, Wong CM, Sham PC, Ng IO. Chiu YT, et al. Among authors: ng io. J Hepatol. 2016 Jun;64(6):1256-64. doi: 10.1016/j.jhep.2016.02.005. Epub 2016 Feb 8. J Hepatol. 2016. PMID: 26867494 Free article.

2

C-terminal truncated hepatitis B virus x protein is associated with metastasis and enhances invasiveness by C-Jun/matrix metalloproteinase protein 10 activation in hepatocellular carcinoma.

Sze KM, Chu GK, Lee JM, Ng IO. Sze KM, et al. Among authors: ng io. Hepatology. 2013 Jan;57(1):131-9. doi: 10.1002/hep.25979. Hepatology. 2013. PMID: 22821423

3

Virus-Clip: a fast and memory-efficient viral integration site detection tool at single-base resolution with annotation capability.

Ho DW, Sze KM, Ng IO. Ho DW, et al. Among authors: ng io. Oncotarget. 2015 Aug 28;6(25):20959-63. doi: 10.18632/oncotarget.4187. Oncotarget. 2015. PMID: 26087185 Free PMC article.

4

Expression of insulin-like growth factor II mRNA in hepatocellular carcinoma.

Ng IO, Lee JM, Srivastava G, Ng M. Ng IO, et al. Among authors: ng m. J Gastroenterol Hepatol. 1998 Feb;13(2):152-7. doi: 10.1111/j.1440-1746.1998.tb00630.x. J Gastroenterol Hepatol. 1998. PMID: 10221816

5

Role of hepatitis B virus X protein in liver cancer.

Ng IO, Sze KM, Chu GK. Ng IO, et al. Hong Kong Med J. 2015 Jun;21 Suppl 4:27-30. Hong Kong Med J. 2015. PMID: 26157100 Free article. No abstract available.

6

Gender disparity of hepatocellular carcinoma: role of hepatitis B virus X protein and androgen receptor.

Chiu YT, Ng IO. Chiu YT, et al. Among authors: ng io. Hong Kong Med J. 2016 Jun;22(3 Suppl 4):43-7. Hong Kong Med J. 2016. PMID: 27390010 Free article. No abstract available.

7

Long non-coding RNA HOTTIP is frequently up-regulated in hepatocellular carcinoma and is targeted by tumour suppressive miR-125b.

Tsang FH, Au SL, Wei L, Fan DN, Lee JM, Wong CC, Ng IO, Wong CM. Tsang FH, et al. Among authors: ng io. Liver Int. 2015 May;35(5):1597-606. doi: 10.1111/liv.12746. Epub 2015 Jan 27. Liver Int. 2015. PMID: 25424744

8

Hepatic IFIT3 predicts interferon-α therapeutic response in patients of hepatocellular carcinoma.

Yang Y, Zhou Y, Hou J, Bai C, Li Z, Fan J, Ng IOL, Zhou W, Sun H, Dong Q, Lee JMF, Lo CM, Man K, Yang Y, Li N, Ding G, Yu Y, Cao X. Yang Y, et al. Hepatology. 2017 Jul;66(1):152-166. doi: 10.1002/hep.29156. Epub 2017 May 26. Hepatology. 2017. PMID: 28295457

9

APOBEC3B promotes hepatocarcinogenesis and metastasis through novel deaminase-independent activity.

Ma W, Ho DW, Sze KM, Tsui YM, Chan LK, Lee JM, Ng IO. Ma W, et al. Among authors: ng io. Mol Carcinog. 2019 May;58(5):643-653. doi: 10.1002/mc.22956. Epub 2019 Jan 6. Mol Carcinog. 2019. PMID: 30575099

10

Molecular pathogenesis of hepatocellular carcinoma.

Wong CM, Ng IO. Wong CM, et al. Among authors: ng io. Liver Int. 2008 Feb;28(2):160-74. doi: 10.1111/j.1478-3231.2007.01637.x. Epub 2007 Dec 6. Liver Int. 2008. PMID: 18069974 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

440 results

Search Page

Filters